The 973 Project(Grant No.2009CB930300);Scientific and Technological Major Special Project -"Significant Creation of New Drugs"(Grant No.2009ZX09310-001).
Sorafenib is a novel antitumor drug,which is poorly absorbed in the gastrointestinal tract due to its low solubility in water.To improve the bioavailability of sorafenib,a self-microemulsifying drug delivery system(SM...
Foundation items: The 973 Project (Grant No. 2009CB930300), Scientific and Technological Major Special Project - "Significant Creation of New Drugs" (Grant No. 2009ZX09310-001).
Sorafenib is a novel antitumor drug, which is poorly absorbed in the gastrointestinal tract due to its low solubility in water. To improve the bioavailability of sorafenib, a self-microemulsifying drug delivery system...